291 filings
Page 3 of 15
EFFECT
iuw3 r53oavu7ytkpi4
11 May 21
Notice of effectiveness
12:15am
424B5
bo31s mewao
10 May 21
Prospectus supplement for primary offering
4:59pm
424B5
4kyb346mvxcw8g
10 May 21
Prospectus supplement for primary offering
4:55pm
CORRESP
av4pjneufbei7
6 May 21
Correspondence with SEC
12:00am
UPLOAD
lu028uhd cgkry0tu
5 May 21
Letter from SEC
12:00am
DEFA14A
tbduiry6k 3x
29 Apr 21
Additional proxy soliciting materials
7:16am
8-K
rsdcqp
29 Apr 21
Genocea Provides First Quarter 2021 Corporate Update
7:13am
8-K
5t3f0lw
14 Apr 21
Departure of Directors or Certain Officers
4:03pm
S-8
y03b014dn
22 Feb 21
Registration of securities for employees
4:39pm
8-K
3pvw6agr2ejp
11 Feb 21
Genocea Provides Fourth Quarter 2020 Corporate Update
7:31am
8-K
kj6cgdpnzh7vjzq 9z
4 Jan 21
Regulation FD Disclosure
4:44pm
8-K
r7ld4v8fhgdqvegx
18 Nov 20
Regulation FD Disclosure
7:56am
8-K
pgkjv97wkg1jkfl
9 Nov 20
Regulation FD Disclosure
5:20pm
8-K
rd1 ti1fmic4t96lmmxh
9 Nov 20
Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020
8:05am